Hepatitis C virus infection. Biological and immunological features

Area of Science:

• Hepatology
• Virology
• Immunology

Background:

• Hepatitis C virus (HCV) identification improved understanding of non-A, non-B hepatitis.
• Antibodies to HCV antigens are common, with some linked to high viral loads.
• Acute hepatitis C frequently progresses to chronic infection, cirrhosis, and hepatocellular carcinoma.

Purpose of the Study:

• To define histopathological and clinical features of HCV infection.
• To investigate the relationship between immune response and hepatitis C disease activity.
• To explore HCV's role in autoimmune manifestations.

Main Methods:

• Utilized sensitive and specific immune techniques for HCV identification.
• Assessed antibody presence against different HCV antigens.
• Analyzed peripheral blood mononuclear cell (PBMC) proliferation in response to HCV antigens (NS3, core).
• Examined liver tissue for histopathological markers of immune-mediated damage.

Main Results:

• Antibodies to HCV antigens, like anti-E1 and anti-E2/NS1, correlate with viremia.
• Over 60% of acute hepatitis C cases become chronic; 10% of cirrhotic cases develop hepatocellular carcinoma.
• PBMC proliferation to NS3 is linked to self-limiting hepatitis, while core antigen stimulation indicates chronic hepatitis.
• Histopathology reveals immune involvement (lymphoid aggregates, inflammation) in liver damage.

Conclusions:

• HCV infection often leads to chronic disease and significant long-term complications.
• Immune responses play a critical role in hepatitis C pathogenesis and disease outcomes.
• HCV may trigger autoimmune phenomena through immune-mediated mechanisms in chronic infection.